Walgreens Boots Alliance Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Walgreens Boots Alliance han disminuido a una tasa media anual de -50.6%, mientras que en la industria Consumer Retailing los beneficios crecieron en un 18.5% anualmente. Los ingresos han ido creciendo a una tasa media de 3.3% al año.

Información clave

-50.6%

Tasa de crecimiento de los beneficios

-50.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Consumer Retailing	18.8%
Tasa de crecimiento de los ingresos	3.3%
Rentabilidad financiera	-126.8%
Margen neto	-5.8%
Última actualización de beneficios	31 Aug 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Walgreens Boots Alliance. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

LSE:0LSZ Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Aug 24	147,658	-8,636	25,685
31 May 24	145,533	-5,811	25,788
29 Feb 24	144,597	-6,037	26,123
30 Nov 23	142,406	574	25,805
31 Aug 23	139,081	-3,080	25,785
31 May 23	136,108	-3,315	26,031
28 Feb 23	133,291	-3,144	25,591
30 Nov 22	132,184	-2,964	25,531
31 Aug 22	132,703	4,337	25,246
31 May 22	134,516	5,111	26,292
28 Feb 22	135,948	5,926	25,909
30 Nov 21	134,972	5,965	25,232
31 Aug 21	132,509	1,994	24,165
31 May 21	128,617	1,972	23,305
28 Feb 21	124,952	-926	23,194
30 Nov 20	123,509	-981	23,052
31 Aug 20	121,982	179	23,144
31 May 20	125,566	519	23,676
29 Feb 20	129,792	3,339	24,269
30 Nov 19	132,984	3,628	24,521
31 Aug 19	120,074	3,816	23,183
31 May 19	136,354	4,817	25,135
28 Feb 19	136,097	5,133	25,112
30 Nov 18	134,590	5,326	25,065
31 Aug 18	131,537	5,024	24,638
31 May 18	128,244	4,314	23,745
28 Feb 18	124,028	4,134	23,520
30 Nov 17	120,453	3,845	23,067
31 Aug 17	118,214	4,078	23,618
31 May 17	116,701	4,306	23,115
28 Feb 17	116,081	4,247	23,046
30 Nov 16	116,819	4,117	23,302
31 Aug 16	117,351	4,173	23,425
31 May 16	117,237	3,169	23,409
29 Feb 16	116,534	3,368	23,433
30 Nov 15	112,923	4,480	22,996
31 Aug 15	103,444	4,220	21,669
31 May 15	93,979	3,973	20,224
28 Feb 15	84,585	3,385	18,611
30 Nov 14	77,617	2,059	17,661
31 Aug 14	76,392	1,932	17,691
31 May 14	75,276	2,810	17,684
28 Feb 14	74,188	2,720	17,579
30 Nov 13	73,230	2,760	17,473

Ingresos de calidad: 0LSZ actualmente no es rentable.

Margen de beneficios creciente: 0LSZ actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 0LSZ no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 50.6% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 0LSZ en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: 0LSZ no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Consumer Retailing (9.3%).

Rentabilidad financiera

Alta ROE: 0LSZ tiene una rentabilidad financiera negativa (-126.83%), ya que actualmente no es rentable.

Walgreens Boots Alliance Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2024 earnings released: US$10.01 loss per share (vs US$3.57 loss in FY 2023)

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.14 in 3Q 2023)

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Second quarter 2024 earnings released: US$6.85 loss per share (vs US$0.81 profit in 2Q 2023)

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Recent updates

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Full year 2024 earnings released: US$10.01 loss per share (vs US$3.57 loss in FY 2023)

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.14 in 3Q 2023)

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

Second quarter 2024 earnings released: US$6.85 loss per share (vs US$0.81 profit in 2Q 2023)

New major risk - Financial position

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

First quarter 2024 earnings released: US$0.078 loss per share (vs US$4.31 loss in 1Q 2023)

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: US$3.57 loss per share (vs US$5.02 profit in FY 2022)

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Upcoming dividend of US$0.48 per share at 6.6% yield

High number of new directors

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

Third quarter 2023 earnings released: EPS: US$0.14 (vs US$0.33 in 3Q 2022)

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Upcoming dividend of US$0.48 per share at 6.1% yield

CEO & Director recently bought US$340k worth of stock

Second quarter 2023 earnings released: EPS: US$0.81 (vs US$1.02 in 2Q 2022)

Upcoming dividend of US$0.48 per share at 5.2% yield

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

First quarter 2023 earnings released: US$4.31 loss per share (vs US$4.14 profit in 1Q 2022)

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Independent Director recently sold US$661k worth of stock

Upcoming dividend of US$0.48 per share

Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022

Full year 2022 earnings released: EPS: US$5.02 (vs US$2.31 in FY 2021)

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million.

John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion.

Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022